Show news: from last 30 days (default), 60 days, 90 days, last visit or all

Syringe Driver Survey Database migration to MedicinesComplete - January 2023

Syringe Driver Survey Database has moved to MedicinesComplete and is no longer available on palliativedrugs.com.

It has been renamed to PCF’s Syringe Driver Database and is now accessed through Drug Compatibility Checker.

Drug Compatibility Checker, through MedicinesComplete is a new tool providing essential compatibility knowledge to support the administration of injectable drugs combining published data and clinical practice reports.

Find out more about Drug Compatibility Checker:https://about.medicinescomplete.com/publication/drug-compatibility-checker/

If you have a subscription to Palliative Care Formulary through MedicinesComplete, you will have access to PCF’s Syringe Driver Database through Drug Compatibility Checker, at no charge through 2023. 

To contribute to PCF’s Syringe Driver Database please continue to submit a clinical practice report using palliativedrugs.com here: https://www.palliativedrugs.com/syringe-driver-database.html

To learn more about a subscription to the Palliative Care Formulary through MedicinesComplete, please contact us here: https://info.medicinescomplete.com/sales

If you have any questions regarding access to PCF’s Syringe Driver Database or would like to renew your subscription to Palliative Care Formulary, please contact pharmpress-support@rpharms.com.


Hyoscine butylbromide ampoules (Buscopan) shortage - UPDATE

6th February 2018

There is a national shortage of hyoscine butylbromide injection (Buscopan) in the UK, as Sanofi (the sole supplier of this product) is out of stock. New supplies are expected by the end of this week (5th February 2018). However, some units have already run out of stock. Glycopyrronium injection can be considered as an unauthorized alternative in the palliative care seting for the management of inoperable intestinal obstruction or as an antispasmodic. See PCF6 Antimuscarinics and PCF6 Glycopyrronium monographs for more detail.

08/02/18 Update

Sanofi have confirmed that supplies of hyoscine butylbromide injection (Buscopan) have now been released and stock has been delivered to wholesalers throughout the UK on the 7th and 8th February 2018. It should be available for ordering within 24h. They have advised that the available volume is sufficient to meet normal UK requirements and that there should be no further delays to future delivery schedules. In order to prevent further strain on the supply chain they have asked that people refrain from excess ordering.

click here to view